[go: up one dir, main page]

AR240044A1 - Procedimiento para elaborar nuevos derivados de la quinolinona y sus sales. - Google Patents

Procedimiento para elaborar nuevos derivados de la quinolinona y sus sales.

Info

Publication number
AR240044A1
AR240044A1 AR294972A AR29497283A AR240044A1 AR 240044 A1 AR240044 A1 AR 240044A1 AR 294972 A AR294972 A AR 294972A AR 29497283 A AR29497283 A AR 29497283A AR 240044 A1 AR240044 A1 AR 240044A1
Authority
AR
Argentina
Prior art keywords
quinolinone
salts
procedure
develop new
new derivatives
Prior art date
Application number
AR294972A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AR240044A1 publication Critical patent/AR240044A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR294972A 1981-03-24 1983-11-30 Procedimiento para elaborar nuevos derivados de la quinolinona y sus sales. AR240044A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH198681 1981-03-24

Publications (1)

Publication Number Publication Date
AR240044A1 true AR240044A1 (es) 1990-01-31

Family

ID=4223231

Family Applications (4)

Application Number Title Priority Date Filing Date
AR82288857A AR242189A1 (es) 1981-03-24 1982-03-24 Un procedimiento para la preparacion de nuevos derivados de quinolinona y sus sales.
AR294972A AR240044A1 (es) 1981-03-24 1983-11-30 Procedimiento para elaborar nuevos derivados de la quinolinona y sus sales.
AR83294975A AR242376A1 (es) 1981-03-24 1983-11-30 Procedimiento para elaborar nuevos derivados de la quinolinona y sus sales.
AR29497383A AR240739A1 (es) 1981-03-24 1983-11-30 Procedimiento para preparar derivados de quinolinona

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR82288857A AR242189A1 (es) 1981-03-24 1982-03-24 Un procedimiento para la preparacion de nuevos derivados de quinolinona y sus sales.

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR83294975A AR242376A1 (es) 1981-03-24 1983-11-30 Procedimiento para elaborar nuevos derivados de la quinolinona y sus sales.
AR29497383A AR240739A1 (es) 1981-03-24 1983-11-30 Procedimiento para preparar derivados de quinolinona

Country Status (22)

Country Link
US (1) US4476132A (es)
EP (1) EP0062001B1 (es)
JP (1) JPH066576B2 (es)
AR (4) AR242189A1 (es)
AT (1) ATE27451T1 (es)
AU (1) AU560003B2 (es)
CY (1) CY1412A (es)
DE (1) DE3276432D1 (es)
DK (1) DK159427C (es)
ES (7) ES8400092A1 (es)
FI (1) FI77853C (es)
GB (1) GB2095668B (es)
GR (1) GR78345B (es)
HK (1) HK3988A (es)
HU (1) HU192103B (es)
IE (1) IE53158B1 (es)
IL (1) IL65327A0 (es)
MY (1) MY8700806A (es)
NO (1) NO160074C (es)
NZ (1) NZ200106A (es)
PT (1) PT74634B (es)
ZA (1) ZA821957B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58219166A (ja) * 1982-06-14 1983-12-20 Nippon Shinyaku Co Ltd 4−キノロン誘導体
JPS58225065A (ja) * 1982-06-21 1983-12-27 Nippon Shinyaku Co Ltd 2−キノロン誘導体
US4675432A (en) * 1986-08-29 1987-06-23 American Cyanamid Company Method for the preparation of anilinofumarate
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
EP1332133B1 (en) * 2000-10-02 2008-07-09 Janssen Pharmaceutica N.V. Metabotropic glutamate receptor antagonists
AU2003226737B2 (en) * 2002-03-29 2008-09-04 Janssen Pharmaceutica N.V. Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
AU2013331493A1 (en) 2012-10-16 2015-04-09 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORyt
ME02794B (me) 2012-10-16 2018-01-20 Janssen Pharmaceutica Nv Metilen vezani hinolinil modulatori ror-gama-t
CA2888485C (en) 2012-10-16 2021-01-26 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of ror.gamma.t
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
BR112016008215A2 (pt) 2013-10-15 2017-09-26 Janssen Pharmaceutica Nv moduladores de quinolinila ligados por alquila de roryt
ES2742843T3 (es) 2013-10-15 2020-02-17 Janssen Pharmaceutica Nv Moduladores de quinolinilo de ROR(gamma)t

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB830832A (en) * 1957-02-15 1960-03-23 Ici Ltd New quinolones and therapeutic compositions containing them
GB1013224A (en) * 1962-06-21 1965-12-15 Ici Ltd Heterocyclic aminoethanols
CH529136A (de) * 1966-09-29 1972-10-15 Ciba Geigy Ag Verfahren zur Herstellung von heterocyclischen Carbonsäuren
US3496184A (en) * 1969-03-18 1970-02-17 Ciba Geigy Corp Cyclopropylmethoxy-3-quinoline carboxylic acids and esters
NL7101049A (es) * 1970-01-28 1971-07-30
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CA942748A (en) * 1970-09-18 1974-02-26 Venkatachala L. Narayanan 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds
US4190659A (en) * 1973-08-27 1980-02-26 Sandoz, Inc. Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters
US4086349A (en) * 1975-07-30 1978-04-25 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinolopyran-4-one-2-carboxylic acid derivatives and salts thereof as novel compounds and as medicines for treatment of allergic asthma
JPS609511B2 (ja) * 1976-07-16 1985-03-11 大塚製薬株式会社 5−カルボスチリルメタノ−ル誘導体
JPS609713B2 (ja) * 1976-10-08 1985-03-12 大塚製薬株式会社 カルボスチリル誘導体
US4186201A (en) * 1977-02-07 1980-01-29 Riker Laboratories, Inc. Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds
US4187309A (en) * 1977-06-20 1980-02-05 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4119720A (en) * 1977-07-06 1978-10-10 Sandoz, Inc. Unsaturated esters of 4-hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
DE2806879A1 (de) * 1978-02-17 1979-08-23 Sandoz Ag 4-hydroxy-2-chinolinon-3-carbonsaeure- esterderivate

Also Published As

Publication number Publication date
ES523340A0 (es) 1985-03-01
AR240739A1 (es) 1990-10-31
AR242189A1 (es) 1993-03-31
ES523341A0 (es) 1985-02-16
EP0062001A3 (en) 1983-01-26
DE3276432D1 (en) 1987-07-02
ES8503662A1 (es) 1985-03-01
ZA821957B (en) 1983-02-23
ES8503663A1 (es) 1985-03-01
ES510685A0 (es) 1983-10-16
GR78345B (es) 1984-09-26
PT74634A (de) 1982-04-01
AU560003B2 (en) 1987-03-26
JPS57192366A (en) 1982-11-26
FI820983L (fi) 1982-09-25
CY1412A (en) 1988-04-22
GB2095668B (en) 1985-04-11
US4476132A (en) 1984-10-09
DK130382A (da) 1982-09-25
ES523342A0 (es) 1985-03-01
NO160074C (no) 1989-03-08
NO820959L (no) 1982-09-27
GB2095668A (en) 1982-10-06
AU8181982A (en) 1982-09-30
IL65327A0 (en) 1982-05-31
ES8400092A1 (es) 1983-10-16
ES523337A0 (es) 1985-03-01
NZ200106A (en) 1985-07-31
MY8700806A (en) 1987-12-31
ES8503661A1 (es) 1985-03-01
ATE27451T1 (de) 1987-06-15
ES523338A0 (es) 1985-03-01
ES8503334A1 (es) 1985-02-16
HU192103B (en) 1987-05-28
JPH066576B2 (ja) 1994-01-26
ES8503664A1 (es) 1985-03-01
HK3988A (en) 1988-01-22
DK159427B (da) 1990-10-15
DK159427C (da) 1991-03-18
FI77853C (fi) 1989-05-10
NO160074B (no) 1988-11-28
PT74634B (de) 1984-11-26
ES523339A0 (es) 1985-03-01
FI77853B (fi) 1989-01-31
IE820670L (en) 1982-09-24
IE53158B1 (en) 1988-08-03
AR242376A1 (es) 1993-03-31
ES8503665A1 (es) 1985-03-01
EP0062001A2 (de) 1982-10-06
EP0062001B1 (de) 1987-05-27

Similar Documents

Publication Publication Date Title
AR240807A1 (es) Procedimiento para obtener derivados de benzazepin-2-ona y sus sales
AR228444A1 (es) Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales
AR229103A1 (es) Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales
ES487464A0 (es) Procedimiento de preparacion de nuevos derivados aldehidos peptidil-argininos y de sus sales
AR228575A1 (es) Procedimiento para obtener derivados de 7-hidroximetil o 7-carboxicamptotecina y sus sales
ES509693A0 (es) Derivados de carbostirilo y sus sales.
AR227731A1 (es) Procedimiento para obtener nuevos derivados de((piperidil-2)-2-etil)-4-quinoleina y sus sales
AR222828A1 (es) Procedimiento para la preparacion de 2,3,4,5-tetrahidro-6-feniltio-1h-3-benzazepinas y sus sales
AR240044A1 (es) Procedimiento para elaborar nuevos derivados de la quinolinona y sus sales.
ES506222A0 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
AR225922A1 (es) Procedimiento para preparar nuevos derivados de 3-carbamoil-sulfonamido-4-amino-piridina y sus sales
AR221080A1 (es) Procedimiento para obtener nuevos derivados de propanona y sus sales
ES502643A0 (es) Procedimiento para la preparacion de compuestos de aril-fe- nil-acetileno y sus sales amonicas
AR228144A1 (es) Procedimiento para obtener derivados de 5-fenil-triazolidina-2,4-diona y sus sales
ES530269A0 (es) Derivados de indano y sus sales
AR212468A1 (es) Procedimiento para la preparacion de nuevos derivados de w-alquilamidas de acidos w amino-carboxilicos y sus sales
AR241905A1 (es) Procedimiento para obtener nuevos derivados de carboestirilo y sus sales.
ES546619A0 (es) Derivados de 2,3-dihidro-1h-indeno y sus sales
AR227272A1 (es) Procedimiento para la obtencion de compuestos de n-oxaciclil-alquil-piperidil-diaza y sus sales
AR228586A1 (es) Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables
AR240828A1 (es) Procedimiento para obtener nuevos derivados de 1h,3h-pirrolo|1,2-c¨tiazol y sus sales
AR228036A1 (es) Procedimiento para obtener derivados de 1-tio-alcanoilprolina y sus sales
AR224610A1 (es) Procedimiento para obtener derivados,de acidos benzacil-benzimidazol-2-carboxilicos o de 2-hidroximetilo y sus sales
AR226288A1 (es) Procedimiento para la produccion de nuevas 4-alquiltiofenoxi alquilaminas y sus sales
ES511329A0 (es) "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales".